Leah J. Hogdal

3.2k total citations
20 papers, 831 citations indexed

About

Leah J. Hogdal is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Leah J. Hogdal has authored 20 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Hematology and 4 papers in Genetics. Recurrent topics in Leah J. Hogdal's work include Acute Myeloid Leukemia Research (9 papers), Protein Degradation and Inhibitors (3 papers) and Cell death mechanisms and regulation (3 papers). Leah J. Hogdal is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Protein Degradation and Inhibitors (3 papers) and Cell death mechanisms and regulation (3 papers). Leah J. Hogdal collaborates with scholars based in United States, Germany and Australia. Leah J. Hogdal's co-authors include Maria P. Arrate, Michael R. Savona, Haley E. Ramsey, Agnieszka E. Gorska, Melissa A. Fischer, Edward T. Olejniczak, Londa Fuller, Gregory D. Ayers, John Sensintaffar and Taekyu Lee and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Gastroenterology.

In The Last Decade

Leah J. Hogdal

20 papers receiving 824 citations

Peers

Leah J. Hogdal
Fiona C. Kimberley Netherlands
Christelle Dousset France
Bart Nijmeijer Netherlands
Samir Tawadros Germany
Kursteen S. Price United States
Anagh A. Sahasrabuddhe United States
Shruti Bhatt United States
Karen Froning United States
M Crawford Australia
Emma F. Barry Australia
Fiona C. Kimberley Netherlands
Leah J. Hogdal
Citations per year, relative to Leah J. Hogdal Leah J. Hogdal (= 1×) peers Fiona C. Kimberley

Countries citing papers authored by Leah J. Hogdal

Since Specialization
Citations

This map shows the geographic impact of Leah J. Hogdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leah J. Hogdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leah J. Hogdal more than expected).

Fields of papers citing papers by Leah J. Hogdal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leah J. Hogdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leah J. Hogdal. The network helps show where Leah J. Hogdal may publish in the future.

Co-authorship network of co-authors of Leah J. Hogdal

This figure shows the co-authorship network connecting the top 25 collaborators of Leah J. Hogdal. A scholar is included among the top collaborators of Leah J. Hogdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leah J. Hogdal. Leah J. Hogdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Powles, Thomas, Michiel S. van der Heijden, Shilpa Gupta, et al.. (2024). 1966MO EV-302: Exploratory analysis of nectin-4 expression and response to 1L enfortumab vedotin (EV) + pembrolizumab (P) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC). Annals of Oncology. 35. S1137–S1138. 13 indexed citations
2.
Zeidan, Amer M., Uma Borate, Daniel A. Pollyea, et al.. (2021). Venetoclax and Azacitidine in the Treatment of Patients with Relapsed/Refractory Myelodysplastic Syndrome. Blood. 138(Supplement 1). 537–537. 13 indexed citations
3.
Cojocari, Dan, Julie J. Purkal, Maria P. Arrate, et al.. (2021). Pevonedistat and azacitidine upregulate NOXA (PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia. Haematologica. 107(4). 825–835. 26 indexed citations
4.
Wei, Andrew H., Jacqueline S. Garcia, Uma Borate, et al.. (2021). MDS-158: Updated Safety and Efficacy of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Treatment-Naïve, Higher-Risk Myelodysplastic Syndromes: Phase 1b Results. Clinical Lymphoma Myeloma & Leukemia. 21. S343–S343. 4 indexed citations
5.
Garcia, Jacqueline S., Andrew H. Wei, Uma Borate, et al.. (2020). Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Higher-Risk Myelodysplastic Syndrome: A Phase 1b Study. Blood. 136(Supplement 1). 55–57. 36 indexed citations
6.
Ramsey, Haley E., Melissa A. Fischer, Taekyu Lee, et al.. (2018). A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia. Cancer Discovery. 8(12). 1566–1581. 254 indexed citations
7.
Gutierrez‐Martinez, Paula, Leah J. Hogdal, Rumani Singh, et al.. (2018). Diminished apoptotic priming and ATM signalling confer a survival advantage onto aged haematopoietic stem cells in response to DNA damage. Nature Cell Biology. 20(4). 413–421. 47 indexed citations
8.
Saito, Yoriko, Yoshiki Mochizuki, Ikuko Ogahara, et al.. (2017). Overcoming mutational complexity in acute myeloid leukemia by inhibition of critical pathways. Science Translational Medicine. 9(413). 12 indexed citations
9.
Montero, Joan, Jason Stephansky, Tianyu Cai, et al.. (2016). Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax. Cancer Discovery. 7(2). 156–164. 144 indexed citations
10.
Fischer, Melissa A., Sharon Friedlander, Leah J. Hogdal, et al.. (2016). Combination of Selective Inhibitor of Nuclear Export (SINE) Compounds, Selinexor and KPT-8602, with Venetoclax (ABT-199) Displays Enhanced Activity in Leukemia and Large Cell Lymphoma. Blood. 128(22). 3949–3949. 5 indexed citations
11.
Montero, Joan, Jason Stephansky, Tianyu Cai, et al.. (2016). Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Is Highly BCL-2 Dependent and Sensitive to Venetoclax. Blood. 128(22). 4045–4045. 3 indexed citations
12.
Bhola, Patrick, Brenton G. Mar, R. Coleman Lindsley, et al.. (2016). Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia. Journal of Clinical Investigation. 126(10). 3827–3836. 34 indexed citations
13.
Sensintaffar, John, Allison L. Arnold, Craig M. Goodwin, et al.. (2016). Abstract 3727: Small molecule Mcl-1 inhibitors induce apoptosis and death in multiple cancer subtypes in vitro. Cancer Research. 76(14_Supplement). 3727–3727. 1 indexed citations
14.
Hogdal, Leah J., Brenda Chyla, Evelyn McKeegan, et al.. (2015). Abstract B10: Studying BCL-2 dependence using BH3 profiling in a phase 2 clinical trial of ABT-199 in acute myeloid leukemia.. Clinical Cancer Research. 21(17_Supplement). B10–B10. 1 indexed citations
15.
Hogdal, Leah J., Brenda Chyla, Evelyn McKeegan, et al.. (2015). Abstract 2834: BH3 profiling predicts clinical response in a phase II clinical trial of ABT-199 (GDC-0199) in acute myeloid leukemia. Cancer Research. 75(15_Supplement). 2834–2834. 2 indexed citations
16.
Çolak, Selçuk, Cheryl Zimberlin, Evelyn Fessler, et al.. (2014). Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells. Cell Death and Differentiation. 21(7). 1170–1177. 91 indexed citations
17.
Hogdal, Leah J., Daniel J. DeAngelo, Richard M. Stone, et al.. (2013). BH3 Profiling Predicts On-Target Cell Death Due To Selective Inhibition Of BCL-2 By ABT-199 In Acute Myelogenous Leukemia. Blood. 122(21). 238–238. 2 indexed citations
18.
Ahlenstiel, Golo, Birgit Edlich, Leah J. Hogdal, et al.. (2011). Early Changes in Natural Killer Cell Function Indicate Virologic Response to Interferon Therapy for Hepatitis C. Gastroenterology. 141(4). 1231–1239.e2. 126 indexed citations
19.
Qazi, Margaret C. Bloch & Leah J. Hogdal. (2010). Hold on: Females modulate sperm depletion from storage sites in the fly Drosophila melanogaster. Journal of Insect Physiology. 56(9). 1332–1340. 13 indexed citations
20.
Edlich, Birgit, Leah J. Hogdal, Barbara Rehermann, & Sven‐Erik Behrens. (2010). Dendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challenge. Vaccine. 28(49). 7764–7773. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fiona C. Kimberley Breakdown of academic impact, for papers by Christelle Dousset Breakdown of academic impact, for papers by Bart Nijmeijer Breakdown of academic impact, for papers by Samir Tawadros Breakdown of academic impact, for papers by Kursteen S. Price Breakdown of academic impact, for papers by Anagh A. Sahasrabuddhe Breakdown of academic impact, for papers by Shruti Bhatt Breakdown of academic impact, for papers by Karen Froning Breakdown of academic impact, for papers by M Crawford Breakdown of academic impact, for papers by Emma F. Barry
Rankless by CCL
2026